$MLSS News

Milestone Scientific Notes Growing Clinical Adoption And Physician Acceptance Of Its CompuFlo Epidural System After Research Publication

Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript

Full Transcript: Milestone Scientific Q1 2026 Earnings Call

Reported earlier, Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est

Milestone Scientific Q1 EPS $(0.01), Inline, Sales $2.162M Miss $2.252M Estimate

Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript

Milestone Scientific Inc (NYSEARCA:MLSS) Beats EPS Estimates and Projects 400% Growth for Key Product in 2026

Milestone Scientific Sees FY2026 Sales $9.800M-$10.200M vs $9.910M Est

Milestone Scientific Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $2.059M Miss $2.309M Estimate

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Milestone Scientific Introduces CompuFlo Advisor Program

Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry

Benchmark Maintains Speculative Buy on Milestone Scientific, Lowers Price Target to $1

Milestone Scientific Inc. (MLSS) Q3 2025 Earnings Call Transcript

Milestone Scientific (MLSS) Stock Jumps Over 35% After Hours — Here's Why

Milestone Scientific shares are trading higher after the company reported better-than-expected Q3 sales results.

Milestone Scientific shares are trading higher after the company reported better-than-expected Q3 sales results.

Milestone Scientific Q3 EPS $(0.01), Inline, Sales $2.360M Beat $2.252M Estimate

Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership

Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification